Cargando…
Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects
Aim: Sphingosine-1-phosphate receptor mediates the egress of lymphocytes from lymphoid organs, and its inhibition results in a decreased number of circulating lymphocytes. The aim of the current study was to investigate the safety and pharmacodynamic and pharmacokinetic characteristics of a novel sp...
Autores principales: | Hwang, Inyoung, Lee, Sang Won, Oh, Jaeseong, Lee, SeungHwan, Jang, In-Jin, Yu, Kyung-Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442045/ https://www.ncbi.nlm.nih.gov/pubmed/36071831 http://dx.doi.org/10.3389/fphar.2022.930615 |
Ejemplares similares
-
Single‐dose of LC51‐0255, a selective S1P(1) receptor modulator, showed dose‐dependent and reversible reduction of absolute lymphocyte count in humans
por: Won Lee, Sang, et al.
Publicado: (2022) -
P02.55. Craniosacral therapy for migraine: a feasibility study
por: Mann, J, et al.
Publicado: (2012) -
Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021) -
Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration
por: Ono, Yoshikazu, et al.
Publicado: (2013) -
Complete genome sequence of Eggerthella lenta type strain (IPP VPI 0255(T))
por: Saunders, Elizabeth, et al.
Publicado: (2009)